
Healthy Aging
Alzheimer’s disease and related dementias affect a staggering number of families, and can devastate the lives of all involved.
The Alzheimer’s Association estimates that one in three seniors in the United States dies with a diagnosis of Alzheimer’s or dementia. 16 million more individuals serve as unpaid caregivers, providing hundreds of billions of dollars of uncompensated care to their loved ones. This caregiving can lead to much higher levels of stress and worse health outcomes for caregivers.
From using passive markers to identify the disease, to the impact of dementia screening and medications to how best to care for patients and their families, Regenstrief Institute is conducting a significant amount of research on dementia.
Researchers are working to understand the relationship between dementia and anticholinergics, as well as how to safely deprescribe medicines. They are also focused on treating and preventing delirium in the intensive care unit, which greatly increases a person’s odds of developing dementia.
A collaborative care model utilizing a team of healthcare workers to treat not only the patient with dementia but the family as well was developed at Regenstrief. Care models such as this along with other interventions to support caregivers are an important cornerstone of dementia research.
Related News & Stories
CMS Innovation Center new care, payment model influenced by Eskenazi Health, Regenstrief Institute, IU School of Medicine
Enhanced support for patients with dementia and their unpaid caregivers A team including Eskenazi Health, Indiana University School of Medicine and Regenstrief Institute has helped guide...
Understanding the intersection of Alzheimer’s disease caregiving and the LGBT experience
Insight into disparities can help meet needs of LGBT people with dementia and their caregivers A new study of caregivers of LGBT older adults living with...
Expanding use of brief assessment tools to increase early detection of mild cognitive impairment in primary care
National expert panel issues strategy recommendations for policymakers and payers INDIANAPOLIS – Mild cognitive impairment, which occurs in about one in six individuals in the U.S.,...
Regenstrief researcher featured speaker at UsAgainstAlzheimer’s event in Washington, DC
Regenstrief Research Scientist Nicole Fowler, PhD, MHSA, was the featured speaker at an UsAgainstAlzheimer’s event in Washington, D.C. The event was the inaugural Brain Health Bash...
Factors influencing participation of Black and White Americans in Alzheimer’s disease biomarker research
Regenstrief researcher leads study of barriers to participation and drivers of engagement The use of Alzheimer’s disease (AD) biomarkers such as amyloid and tau levels to...